Matthew Vander Heiden
Koch Institute for Cancer Research at MIT
| Description | Y/N | Source |
| Grants | no | |
| Salary | yes | Agios Pharmaceuticals - consultant |
| Board Member | yes | Agios Pharmaceuticals - SAB member |
| Stock | yes | Agios Pharmaceuticals - stock holder |
| Expenses | no |
IP Royalty: no
| Planning to mention or discuss specific products or technology of the company(ies) listed above: | no |